QUEENSGATE HOMES LIMITED
Company number 00760869 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: QUEENSGATE HOMES LIMITED
1. Financial Health Score: A-
Queensgate Homes Limited presents the financial picture of a company with an exceptionally strong balance sheet and robust liquidity, but one that appears to be resting between active development cycles. The company's financial vitals are those of a patient in excellent condition but currently in a state of hibernation rather than active exertion. The near-£833k in net assets against minimal liabilities of under £19k represents outstanding financial resilience, though the business may not be deploying its considerable resources to optimal effect.
2. Key Vital Signs
Heart Rate: Cash Position — Strong but Slow Pulse
| Year | Cash | Cash as % of Total Assets |
|---|---|---|
| 2025 | £771,351 | 90.6% |
| 2024 | £786,814 | 90.7% |
| 2023 | £829,441 | 92.2% |
| 2022 | £937,530 | 78.4% |
| 2021 | £158,822 | 14.3% |
| 2020 | £13,019 | 0.7% |
Interpretation: The company's cash reserves are like a strong, steady heartbeat — but one that has slowed considerably. Cash represents over 90% of total assets, indicating the business has successfully collected proceeds from past developments but is currently holding substantial funds in a low-return position. The dramatic transformation from £13k cash in 2020 to over £770k today tells a story of successful project completion and cash collection, but also suggests a prolonged period between active developments.
Blood Pressure: Liquidity Ratio — Exceptionally High
| Metric | 2025 | 2024 |
|---|---|---|
| Current Assets | £850,811 | £866,259 |
| Current Liabilities | £18,778 | £31,822 |
| Current Ratio | 45.3:1 | 27.2:1 |
Interpretation: A current ratio of 45:1 is like blood pressure that's technically perfect but suggests the patient isn't exerting themselves. The company can cover its short-term obligations 45 times over — an extraordinary position that speaks to absolute financial security but also raises the question of whether capital is being under-utilised.
Cholesterol: Liabilities — Dangerously Low (Which Is Good)
| Year | Total Liabilities | Net Assets |
|---|---|---|
| 2025 | £18,778 | £832,493 |
| 2024 | £31,822 | £835,358 |
| 2020 | £1,629,016 | £357,890 |
Interpretation: The company has systematically cleared its liabilities from a peak of £1.629M in 2020 to under £19k today. This is the financial equivalent of clearing arterial blockages — the company's financial system is running cleanly with minimal obligations. The trajectory from heavy leverage to near-zero debt demonstrates disciplined financial management.
Body Temperature: Net Asset Trend — Stable with Slight Cooling
| Year | Net Assets | Year-on-Year Change |
|---|---|---|
| 2025 | £832,493 | -£2,865 (-0.3%) |
| 2024 | £835,358 | +£7,158 (+0.9%) |
| 2023 | £828,200 | +£53,300 (+6.9%) |
| 2022 | £774,900 | +£129,144 (+20.0%) |
| 2021 | £645,756 | +£287,866 (+80.4%) |
| 2020 | £357,890 | -£23,307 (-6.1%) |
Interpretation: Net asset growth has decelerated significantly, from 80% growth in 2021 to a marginal decline of 0.3% in 2025. This cooling trend suggests the company is in a holding pattern — maintaining value but not generating significant new profits. The retained earnings have dipped slightly from £735,358 to £732,493, indicating a small loss or operating costs exceeding income in the latest year.
Muscle Mass: Shareholders' Funds — Well Developed
- Share Capital: £100,000 (unchanged)
- Profit & Loss Reserve: £732,493
- Total Shareholders' Funds: £832,493
Interpretation: The P&L reserve has been built up substantially over the years from £280,654 in 2016 to £732,493 today — a 161% increase. This represents accumulated retained profits and demonstrates the company's ability to generate and retain wealth over time.
3. Diagnosis
Overall Condition: Financially Robust, Operationally Dormant
Queensgate Homes Limited presents a fascinating clinical picture. The company has the financial physique of an elite athlete — strong reserves, minimal debt, excellent liquidity — but appears to be in a state of suspended animation between development projects.
The Recovery Narrative (2019-2025):
The financial history reveals a compelling story. In 2020, the company showed the classic symptoms of an active property developer: high assets (£1.98M) matched by high liabilities (£1.63M), with minimal cash (£13k). This is the balance sheet of a company mid-project — capital deployed, borrowings drawn, properties in development.
By 2021-2022, we see the recovery phase: assets reduced (projects sold), liabilities dramatically cleared, and cash flooding in. The company was converting development inventory into cash and paying down debt.
From 2023 onwards, the patient is in excellent post-recovery condition but inactive. Cash levels remain high (£770k-£830k), stocks are minimal (£78k suggesting some land held for future development), and the business appears to be waiting for the next opportunity.
Key Diagnostic Findings:
-
Exceptional Financial Health: Net assets of £832k against liabilities of only £19k represents a debt-to-equity ratio of just 0.02:1. The company is virtually debt-free.
-
Cash-Heavy Asset Structure: With 90% of assets in cash, the company has maximum financial flexibility but is likely earning minimal returns on these funds. Property development typically generates returns of 15-25% on capital employed — cash deposits earn a fraction of this.
-
Minimal Operating Footprint: With only 2 employees (the director and company secretary), fixed assets of just £460 (computer equipment), and no apparent development activity, the business is running on minimal overheads.
-
Stock Levels Suggest Pipeline Potential: The £78,440 in stocks (likely land held for development) hints at potential future activity, though this figure has remained static between 2024 and 2025.
-
Slight Value Erosion: The marginal decline in net assets and P&L reserve in 2025 suggests the company is incurring operating costs (accounting, filing, administrative) without generating offsetting revenue.
Risk Factors:
- Opportunity Cost: The largest risk is not financial distress but financial underperformance. £770k sitting in bank accounts rather than deployed in development projects represents significant opportunity cost.
- Inflation Erosion: With inflation running above savings rates, the real value of cash holdings is gradually being eroded.
- Age Demographics: As a company incorporated in 1963, now running for over 60 years with what appears to be a single controlling director, succession planning may be a consideration.
4. Recommendations
Prescription for Enhanced Financial Wellness
1. Capital Deployment Strategy (Priority: High) The company should evaluate options for deploying its substantial cash reserves more productively. This could include: - Initiating a new property development project - Investing in a diversified portfolio of assets - Returning surplus capital to shareholders if no development plans exist
Medical analogy: A patient with excellent blood reserves needs to ensure that blood is circulating and oxygenating the body, not just sitting in storage.
2. Development Pipeline Assessment (Priority: Medium) Given the £78,440 in stocks (presumably land), the company should clarify its development intentions: - Is this land being prepared for development? - What is the expected timeline and capital requirement? - Are planning permissions in place or being sought?
3. Cash Management Optimisation (Priority: Medium) Even if holding cash between projects, the company should ensure it's earning the best possible returns: - Consider notice accounts or fixed-term deposits for funds not immediately required - Explore money market funds for better yields while maintaining accessibility - Review banking arrangements to maximise interest income
4. Succession and Continuity Planning (Priority: Medium) With Mr Peter Young as the sole controlling party (100% share ownership) and the company incorporated over 60 years ago: - Document key business relationships and processes - Consider whether current corporate structure supports long-term objectives - Review whether the company's purpose remains aligned with shareholders' intentions
5. Regular Financial Health Check-ups (Priority: Standard) - Monitor the slight decline in P&L reserves to ensure operating costs remain justified - Track whether the stock holding is progressing toward development or should be reassessed - Set clear milestones for capital deployment decisions
Financial Vital Signs Summary Card
| Vital Sign | Reading | Status |
|---|---|---|
| Net Assets | £832,493 | ✅ Excellent |
| Cash Position | £771,351 | ✅ Very Strong |
| Current Ratio | 45.3:1 | ⚠️ Over-liquid |
| Debt-to-Equity | 0.02:1 | ✅ Minimal Leverage |
| Year-on-Year Growth | -0.3% | ⚠️ Slight Decline |
| P&L Reserve Trend | -£2,865 | ⚠️ Marginal Erosion |
| Asset Utilisation | Low | ⚠️ Under-deployed |